🇺🇸 FDA
Pipeline program

internal mammary nodal irradiation

19/317-2101

Phase 3 other active

Quick answer

internal mammary nodal irradiation for Breast Cancer is a Phase 3 program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Breast Cancer
Phase
Phase 3
Modality
other
Status
active

Clinical trials